期刊文献+

肝癌肝移植术后肿瘤复发的围手术期防治措施 被引量:11

Perioperative measures for preventing hepatocellular carcinoma recurrence after liver transplantation
下载PDF
导出
摘要 近年来,肝癌肝移植术后肿瘤复发的临床防治工作得到了飞速的发展,特别是围手术期的防治措施得到了越来越多循证医学研究的佐证,然而囿于肝癌肝移植手术过程复杂、涉及环节众多,如何通过围手术期干预减少肝移植术后肿瘤复发,是肝移植领域热点及难点。文章旨在通过回顾肝癌肝移植术后肿瘤复发的围手术期防治措施,给予外科学研究生以及临床医务人员一定的启发,促进临床医学事业的发展。 In recent years,a rapid development has been achieved in the clinical prevention of hepatocellular carcinoma recurrence after liver transplantation,especially in perioperative management,which are supported by the results of evidence-based studies. However,due to the complicated procedures and varied risk factors for liver transplantation,the prevention of postoperative carcinoma recurrence remains a challenge and a focus of research in liver transplantation. This study reviews the perioperative measures for the prevention of hepatocellular carcinoma recurrence after liver transplantation,aiming to shed some light on this aspect for graduates and clinicians of surgery.
作者 施晓雷
出处 《医学研究生学报》 CAS 北大核心 2017年第8期785-791,共7页 Journal of Medical Postgraduates
关键词 肝移植 肝细胞性肝癌 复发 围手术期 Liver transplantation Hepatocelluar carcinoma Recurrence Perioperative period
  • 相关文献

参考文献4

二级参考文献18

  • 1Mostafa K El Awady,Noha G Bader El Din,Ashraf Tabll,Yaser El Hosary,Ashraf O Abdel Aziz,Hesham El Khayat,Mohsen Salama,Tawfeek H Abdelhafez.IL28B polymorphism and cytomegalovirus predict response to treatment in Egyptian HCV type 4 patients[J].World Journal of Gastroenterology,2013,19(2):290-298. 被引量:8
  • 2Vivarelli M,Cucchetti A,Piscaglia F,et al.Analysis of risk factor for tumor recurrence after liver transplantation for hepatocellular carcinoma:key role of immunosuppression.Liver Transplant,2005,11:497-503. 被引量:1
  • 3Vivarelli M,Cucchetti A,La Barbaetal G,et al.Liver transplantation for hepatocellular carcimoma under calcineurin inhibitor:reassessment of risk factors for tumor recurrence.Ann Surg,2008,248:857-862. 被引量:1
  • 4Shushan Yan,Donghua Xu,Beicheng Sun.Combination of Radiofrequency Ablation with Transarterial Chemoembolization for Hepatocellular Carcinoma: A Meta-Analysis[J].Digestive Diseases and Sciences.2012(11) 被引量:1
  • 5Gerlig Widmann,Peter Schullian,Marion Haidu,Reto Bale.Stereotactic Radiofrequency Ablation (SRFA) of Liver Lesions: Technique Effectiveness, Safety, and Interoperator Performance[J].CardioVascular and Interventional Radiology.2012(3) 被引量:1
  • 6Po Yang,Minghui Liang,Yingxun Zhang,Baozhong Shen.Clinical application of a combination therapy of lentinan, multi-electrode RFA and TACE in HCC[J].Advances in Therapy.2008(8) 被引量:1
  • 7SQ Shen,JJ Xiang,CL Xiong,SM Wu,SS Zhu.Intraoperative radiofrequency thermal ablation combined with portal vein infusion chemotherapy and transarterial chemoembolization for unresectable HCC[].Hepato Gastroenterology.2005 被引量:1
  • 8Parkin DM,Bray F,Ferlay J,et al.Estimating the world cancer burden: Globocan 2000[].International Journal of Cancer.2001 被引量:1
  • 9Bruix J,Sherman M.Management of hepatocellular carcinoma[].Hepatology.2005 被引量:1
  • 10Llovet J M,Bruix J.Systematic review of randomized trials for unresectable hepatocellular carcinoma: chemoembolization improves survival[].Hepatology.2003 被引量:1

共引文献48

同被引文献77

引证文献11

二级引证文献64

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部